These results indicate that the peptide A-specific CTL clone showed cytotoxicity and the ability to produce IFN-γ against HLA-A*02:01+ EML4-ALK+ NSCLC cell lines (Fig. 5). This evidence concerns the gene ALK and non-small cell lung carcinoma.